US Stock MarketDetailed Quotes

NRXP NRX Pharmaceuticals

Watchlist

1.7100
-0.0100-0.58%

Close Sep 16 16:00 ET

1.6700
-0.0400-2.34%

Post 18:08 ET

18.38MMarket Cap-638P/E (TTM)

NRX Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

-13.90%7.05M

-36.43%6M

-37.21%27.84M

-55.44%4.41M

-36.46%5.81M

-14.71%8.19M

-39.92%9.44M

-61.71%44.34M

-81.33%9.89M

-54.52%9.14M

Selling and administrative expenses

4.45%4.25M

-26.53%4.25M

-47.94%14.22M

-65.54%1.87M

-50.24%2.49M

-38.80%4.07M

-43.41%5.79M

-63.56%27.31M

-88.33%5.43M

-63.74%5.01M

-General and administrative expense

4.45%4.25M

-26.53%4.25M

-47.94%14.22M

-65.54%1.87M

-50.24%2.49M

-38.80%4.07M

-43.41%5.79M

-63.56%27.31M

-88.33%5.43M

-63.74%5.01M

Research and development costs

-27.60%2.8M

-52.11%1.75M

-21.47%13.37M

-43.13%2.53M

-19.74%3.31M

30.93%3.87M

-33.43%3.65M

-15.95%17.03M

-30.52%4.46M

-34.21%4.13M

Other operating expenses

----

--250K

--0

----

--250K

----

Operating profit

13.90%-7.05M

36.43%-6M

37.21%-27.84M

55.44%-4.41M

36.46%-5.81M

14.71%-8.19M

39.92%-9.44M

61.71%-44.34M

81.33%-9.89M

54.52%-9.14M

Net non-operating interest income expense

-95.17%7K

-230.13%-203K

50.20%374K

-104.51%-6K

-16.84%79K

530.43%145K

5,300.00%156K

1,483.33%249K

6,750.00%133K

2,000.00%95K

Non-operating interest income

-95.17%7K

-82.69%27K

98.39%494K

-43.08%74K

25.26%119K

530.43%145K

--156K

--249K

--130K

--95K

Non-operating interest expense

--0

--230K

--120K

2,766.67%80K

--40K

--0

-250.00%-3K

--0

Other net income (expense)

-26.71%-854K

81.42%-327K

-162.03%-2.69M

116.46%80K

-800.00%-333K

-125.97%-674K

-177.88%-1.76M

-80.96%4.33M

-102.15%-486K

99.78%-37K

Gain on sale of security

99.26%-5K

81.42%-327K

-974.80%-2.69M

116.46%80K

-800.00%-333K

-681.03%-674K

-1,221.02%-1.76M

-114.78%-250K

-155.93%-486K

99.78%-37K

Special income (charges)

----

--0

----

-78.24%4.58M

--0

-Less：Restructuring and merger&acquisition

----

--0

----

78.12%-4.58M

--0

Other non- operating income (expenses)

---849K

----

Income before tax

9.41%-7.9M

40.86%-6.53M

24.16%-30.15M

57.70%-4.33M

33.26%-6.06M

-24.85%-8.72M

17.91%-11.04M

57.28%-39.75M

66.32%-10.24M

75.48%-9.08M

Income tax

Net income

9.41%-7.9M

40.86%-6.53M

24.16%-30.15M

57.70%-4.33M

33.26%-6.06M

-24.85%-8.72M

17.91%-11.04M

57.28%-39.75M

66.32%-10.24M

75.48%-9.08M

Net income continuous Operations

9.41%-7.9M

40.86%-6.53M

24.16%-30.15M

57.70%-4.33M

33.26%-6.06M

-24.85%-8.72M

17.91%-11.04M

57.28%-39.75M

66.32%-10.24M

75.48%-9.08M

Minority interest income

Net income attributable to the parent company

9.41%-7.9M

40.86%-6.53M

24.16%-30.15M

57.70%-4.33M

33.26%-6.06M

-24.85%-8.72M

17.91%-11.04M

57.28%-39.75M

66.32%-10.24M

75.48%-9.08M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

9.41%-7.9M

40.86%-6.53M

24.14%-30.16M

57.61%-4.34M

33.26%-6.06M

-24.85%-8.72M

17.91%-11.04M

88.61%-39.75M

66.32%-10.24M

75.48%-9.08M

Basic earnings per share

38.02%-0.75

55.42%-7.4

33.33%-4

66.67%-0.5

50.00%-0.7

-10.00%-1.21

-690.48%-16.6

91.94%-6

70.99%-1.5

79.29%-1.4

Diluted earnings per share

38.02%-0.75

55.42%-7.4

33.33%-4

66.67%-0.5

50.00%-0.7

-10.00%-1.21

-690.48%-16.6

91.94%-6

70.99%-1.5

79.29%-1.4

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	-13.90%7.05M	-36.43%6M	-37.21%27.84M	-55.44%4.41M	-36.46%5.81M	-14.71%8.19M	-39.92%9.44M	-61.71%44.34M	-81.33%9.89M	-54.52%9.14M
Selling and administrative expenses	4.45%4.25M	-26.53%4.25M	-47.94%14.22M	-65.54%1.87M	-50.24%2.49M	-38.80%4.07M	-43.41%5.79M	-63.56%27.31M	-88.33%5.43M	-63.74%5.01M
-General and administrative expense	4.45%4.25M	-26.53%4.25M	-47.94%14.22M	-65.54%1.87M	-50.24%2.49M	-38.80%4.07M	-43.41%5.79M	-63.56%27.31M	-88.33%5.43M	-63.74%5.01M
Research and development costs	-27.60%2.8M	-52.11%1.75M	-21.47%13.37M	-43.13%2.53M	-19.74%3.31M	30.93%3.87M	-33.43%3.65M	-15.95%17.03M	-30.52%4.46M	-34.21%4.13M
Other operating expenses	----	----	--250K	--0	----	--250K	----	----	----	----
Operating profit	13.90%-7.05M	36.43%-6M	37.21%-27.84M	55.44%-4.41M	36.46%-5.81M	14.71%-8.19M	39.92%-9.44M	61.71%-44.34M	81.33%-9.89M	54.52%-9.14M
Net non-operating interest income expense	-95.17%7K	-230.13%-203K	50.20%374K	-104.51%-6K	-16.84%79K	530.43%145K	5,300.00%156K	1,483.33%249K	6,750.00%133K	2,000.00%95K
Non-operating interest income	-95.17%7K	-82.69%27K	98.39%494K	-43.08%74K	25.26%119K	530.43%145K	--156K	--249K	--130K	--95K
Non-operating interest expense	--0	--230K	--120K	2,766.67%80K	--40K	--0	--0	--0	-250.00%-3K	--0
Other net income (expense)	-26.71%-854K	81.42%-327K	-162.03%-2.69M	116.46%80K	-800.00%-333K	-125.97%-674K	-177.88%-1.76M	-80.96%4.33M	-102.15%-486K	99.78%-37K
Gain on sale of security	99.26%-5K	81.42%-327K	-974.80%-2.69M	116.46%80K	-800.00%-333K	-681.03%-674K	-1,221.02%-1.76M	-114.78%-250K	-155.93%-486K	99.78%-37K
Special income (charges)	----	----	--0	--0	--0	----	----	-78.24%4.58M	--0	--0
-Less：Restructuring and merger&acquisition	----	----	--0	--0	--0	----	----	78.12%-4.58M	--0	--0
Other non- operating income (expenses)	---849K	----	----	----	----	----	----	----	----	----
Income before tax	9.41%-7.9M	40.86%-6.53M	24.16%-30.15M	57.70%-4.33M	33.26%-6.06M	-24.85%-8.72M	17.91%-11.04M	57.28%-39.75M	66.32%-10.24M	75.48%-9.08M
Income tax
Net income	9.41%-7.9M	40.86%-6.53M	24.16%-30.15M	57.70%-4.33M	33.26%-6.06M	-24.85%-8.72M	17.91%-11.04M	57.28%-39.75M	66.32%-10.24M	75.48%-9.08M
Net income continuous Operations	9.41%-7.9M	40.86%-6.53M	24.16%-30.15M	57.70%-4.33M	33.26%-6.06M	-24.85%-8.72M	17.91%-11.04M	57.28%-39.75M	66.32%-10.24M	75.48%-9.08M
Minority interest income
Net income attributable to the parent company	9.41%-7.9M	40.86%-6.53M	24.16%-30.15M	57.70%-4.33M	33.26%-6.06M	-24.85%-8.72M	17.91%-11.04M	57.28%-39.75M	66.32%-10.24M	75.48%-9.08M
Preferred stock dividends
Other preferred stock dividends			9K					0
Net income attributable to common stockholders	9.41%-7.9M	40.86%-6.53M	24.14%-30.16M	57.61%-4.34M	33.26%-6.06M	-24.85%-8.72M	17.91%-11.04M	88.61%-39.75M	66.32%-10.24M	75.48%-9.08M
Basic earnings per share	38.02%-0.75	55.42%-7.4	33.33%-4	66.67%-0.5	50.00%-0.7	-10.00%-1.21	-690.48%-16.6	91.94%-6	70.99%-1.5	79.29%-1.4
Diluted earnings per share	38.02%-0.75	55.42%-7.4	33.33%-4	66.67%-0.5	50.00%-0.7	-10.00%-1.21	-690.48%-16.6	91.94%-6	70.99%-1.5	79.29%-1.4
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data